Skip to results
Modify your search
NARROW
1-4 of 4
Authors: Matthew R Grimmer
Sort by
Journal Article
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas Free
Yao Yu and others
Neuro-Oncology, Volume 23, Issue 11, November 2021, Pages 1872–1884, https://doi.org/10.1093/neuonc/noab081
Published: 05 April 2021
Journal Article
Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma Open Access
Lindsey E Jones and others
Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdaa088, https://doi.org/10.1093/noajnl/vdaa088
Published: 16 July 2020
Journal Article
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence Free
Radhika Mathur and others
Neuro-Oncology, Volume 22, Issue 11, November 2020, Pages 1580–1590, https://doi.org/10.1093/neuonc/noaa059
Published: 13 March 2020
Journal Article
Temozolomide-associated hypermutation in gliomas Free
Serah Choi and others
Neuro-Oncology, Volume 20, Issue 10, October 2018, Pages 1300–1309, https://doi.org/10.1093/neuonc/noy016
Published: 14 February 2018